The Ins and Outs of Type I INKT Cell Development
Overview
Molecular Biology
Authors
Affiliations
Natural killer T (NKT) cells are innate-like lymphocytes that bridge the gap between the innate and adaptive immune responses. Like innate immune cells, they have a mature, effector phenotype that allows them to rapidly respond to threats, compared to adaptive cells. NKT cells express T cell receptors (TCRs) like conventional T cells, but instead of responding to peptide antigen presented by MHC class I or II, NKT cell TCRs recognize glycolipid antigen in the context of CD1d. NKT cells are subdivided into classes based on their TCR and antigen reactivity. This review will focus on type I iNKT cells that express a semi invariant Vα14Jα18 TCR and respond to the canonical glycolipid antigen, α-galactosylceramide. The innate-like effector functions of these cells combined with their T cell identity make their developmental path quite unique. In addition to the extrinsic factors that affect iNKT cell development such as lipid:CD1d complexes, co-stimulation, and cytokines, this review will provide a comprehensive delineation of the cell intrinsic factors that impact iNKT cell development, differentiation, and effector functions - including TCR rearrangement, survival and metabolism signaling, transcription factor expression, and gene regulation.
Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy.
Zhang Y, He Y, Dai C, Zhou Z, Miao Y, Zhao Z Cell Rep Methods. 2024; 4(9):100843.
PMID: 39216483 PMC: 11440056. DOI: 10.1016/j.crmeth.2024.100843.
Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R Front Transplant. 2024; 3:1353803.
PMID: 38993780 PMC: 11235242. DOI: 10.3389/frtra.2024.1353803.
Novel lipid antigens for NKT cells in cancer.
Lee M, Webb T Front Immunol. 2023; 14:1173375.
PMID: 37908366 PMC: 10613688. DOI: 10.3389/fimmu.2023.1173375.
Morgan R, Frank C, Greger M, Attaway M, Sigvardsson M, Bartom E J Immunol. 2023; 211(9):1376-1384.
PMID: 37702745 PMC: 10592054. DOI: 10.4049/jimmunol.2200809.
Won H, Liman N, Park J, Park J J Autoimmun. 2023; 138:103059.
PMID: 37216869 PMC: 10330485. DOI: 10.1016/j.jaut.2023.103059.